Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gentamicin is an aminoglycoside antibiotic used to treat various bacterial infections. It works by inhibiting protein synthesis in susceptible bacteria, leading to cell death. Gentamicin is primarily effective against aerobic gram-negative bacteria, though it also shows activity against some gram-positive organisms. Gentamicin is bactericidal and acts by inhibiting protein synthesis in susceptible bacteria. As an aminoglycoside antibiotic, it binds to the 30S ribosomal subunit, preventing the formation of the 70S complex. This leads to misreading of the genetic code and inhibition of protein synthesis, ultimately resulting in bacterial cell death. Gentamicin is used to treat serious bacterial infections in many different parts of the body, including: - Blood infections (septicemia) - Meningitis - Urinary tract infections - Respiratory infections (bronchitis, pneumonia) - Gastrointestinal infections - Skin infections and burns - Bone and joint infections - Endocarditis Gentamicin is active against a wide range of bacteria, primarily: - Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Proteus species, Klebsiella pneumoniae, Enterobacter aerogenes, Serratia species - Some gram-positive bacteria: Staphylococcus species (including methicillin-resistant strains) It is not effective against Neisseria meningitidis, Legionella pneumophila, or anaerobic bacteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gentamicin.